As of Jul 31
| -0.115 / -9.70%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 3.75, with a high estimate of 3.75 and a low estimate of 3.75. The median estimate represents a +250.47% increase from the last price of 1.07.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.